GUMDROP : Efficacy and Safety of oral Kanglaite (KLTc) Gelcap in Men with Prostate Cancer- Randomized, Dose-Ranging Study of KLTc Gelcap on PSA Doubling Time Among Men with Rising PSA

Created by Channing Paller, last modified on Apr 14, 2012

Description:

This study seeks to determine the safety and effectiveness of oral Kanglaite (grass seed oil) in slowing PSA doubling time. Eligible patients will have completed definitive local therapy (surgery, surgery w/ radiation, cryotherapy, radiation/brachytherapy) and has a rising PSA; testosterone = 150 ng/mL; PSADT = 6 mo. Patients with metastatic disease are not eligible.

Link:

http://clinicaltrials.gov/ct2/show/NCT01483586

Site:

Johns Hopkins Hospital

Principal Investigator:

Michael Carducci, M.D.